With regard to tumor development, we favor the explanation that Nfatc2 deficiency facilitates development of plasmablastic malignancies similar to those seen in Fasl-deficient (gld) mice and other mice [31], [41], which might be driven by chronic antigenic stimulation or perhaps by autoantigens [42]. The gene discussed is NFATC2; the disease is neoplasm.